#IDIBELLfellows: Romina Miranda / Marta Valle

07/10/2020 15:00-16:00

Room 205 – Nou aulari UB-Bellvitge
Microsoft Teams Meeting


#IDIBELLconnect: Novel clinical and translational research approaches to mesothelioma, an orphan tumor

Ernest Nadal

Group Leader at Bellvitge Biomedical Research Institute (IDIBELL), Clinical Research in Solid Tumors Group, Oncobell Program
Head of Section of Thoracic, Brain and Head and Neck Tumors, Catalan Institute of Oncology (ICO), Department of Medical Oncology
Associate Professor, University of Barcelona, Department of Clinical Sciences, Campus Bellvitge

09/10/2020 13:00-14:00

Microsoft Teams Meeting


Career Day 2020

21/10/2020 -

21-22 October 2020
This event is being held online


La recerca en temps de pandèmia

Dra. Maria Ángeles Domínguez
Dr. Xavier Solanich

21/10/2020 19:00-

VII Programa de excelencia en el abordaje del paciente con EM de alta actividad

Unitat EM HUB

22/10/2020 -

22-23 Octubre 2020

Sala d’actes Bellvitge University hospital 9.00h


#IDIBELLconnect: RANK a novel therapeutic target in breast cancer

Speaker Eva Gonzalez-Suarez

Transformation and Metastasis Group, Oncobell Program

06/11/2020 13:00-14:00

PhD Day 2020

12/11/2020 -

12-13 November 2020
this event is being held online


#IDIBELLconnect: Generation of protective immunity against infections by removing non-neutralizing/blocking antibodies

Rafael Máñez

Group Leader at the Bellvitge Biomedical Research Institute (IDIBELL), Innate Immunity and Pathology of the Critical Patient Group, Infectious disease and transplantation Program
Director of Intensive Care Department at Bellvitge University Hospital

20/11/2020 13:00-14:00

Microsoft Teams Meeting



Xerrades Sinergia

Òscar Martínez Tirado
Marta Barrachina
Gabriela Jiménez
Anna Veiga
Esteve Fernandez
Susana Jiménez
Rafael Máñez
Mònica Povedano
Miquel Àngel Pujana
Laia Alemany
Montse Nacher

28/11/2020 10:00-19:00

Online i en directe:
https://sinergia.l-h.cat/


#IDIBELLconnect: The mTOR-LARP1 axis and the anabolic reservoir of tumor cells: A new therapeutic target in colorectal cancer and beyond

Antonio Gentilella

Metabolism and Cancer Group, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL)
Department of Physiology and Biochemistry, Faculty of Pharmacy, University of Barcelona

04/12/2020 13:00-14:00

Microsoft Teams Meeting


#IDIBELLconnect: Immunotherapeutic potential of oncolytic Vaccinia viruses

Juan Jose Rojas

Bellvitge Biomedical Research Institute (IDIBELL)
Unitat d’Immunologia, Departament de Patologia i Terapèutica Experimental, Universitat de Barcelona

18/12/2020 13:00-14:00

Microsoft Teams Meeting


Clinical Psychology International Update Seminars – Eating Disorders

Eating disorders (ED) are serious and long-lasting mental disorders that mainly affect women. They begin in adolescence…

Read More

#IDIBELLfellows: Júlia Migó

Role of S100A9 in tumor cell plasticity in breast cancer Júlia Migó – Gynecologic cancer group Advanced…

Read More

Epithelial to mesenchymal transition controls intra-tumour heterogeneity and segregation of labour in breast cancer

Special Seminar Friday, July 12th. 13:00 Sala d’Actes, Pavelló de Govern 1a planta Epithelial to mesenchymal transition…

Read More

#IDIBELLfellows: Laura Casado Medina / Lidia Collado Rodríguez

3D Bioprinted Tubular Cardiac Tissues as a Tool for Cardiac Therapies Laura Casado Medina  – Stem Cell…

Read More

Monòlegs científics Stand-up Science

Dins la programació Summer Experience L’Hospitalet, els investigadors més joves de l’IDIBELL faran els seus monòlegs científics…

Read More

Thesis: H3K9 methylation in haematopoietic stem cell aging and leukaemia

H3K9 methylation in haematopoietic stem cell aging and leukaemia Barbara Walter –  Stem Cell Aging Group Universitat…

Read More

RegenBell 2024 symposium on Stem Cells and Regenerative Medicine

RegenBell is proud to announce the RegenBell 2024 Symposium on Stem Cells and Regenerative Medicine with the…

Read More

#IDIBELLfellows: Ana Amaya Garrido / Marcel Schilling

Exploring Cdc42 as a novel therapeutic target to promote resistance to ischemia/reperfusion injury in aging kidneys Ana…

Read More

Constitutional epimutations in hereditary cancer predisposition

Megan Hitchins – Department of Biomedical Sciences, Cedars-Sinai Medical Center Dr. Megan Hitchins undertakes translational cancer research…

Read More

An Overview of the Increasing Incidence and Possible Causes of Early Onset Colorectal Cancer

Robert Haile – Department of Biomedical Sciences, Cedars-Sinai Medical Center. The research focus of Dr. Robert Haile…

Read More
Scroll to Top